Morgan Stanley Capital’s Comar looks to fill gap in healthcare packaging

Comar, now generating over $200m in revenue, will target select M&A opportunities within the scientific molding, micromolding, silicon and sharps areas.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this